LEADING INNOVATION FOR MORE THAN 30 YEARS,  MEDTRONIC HAS COMMITTED
TO TRANSFORMING
DIABETES CARE.

 

 

Exciting News!

Megaphone exciting news about Diabetes management

We’ve filed a Licence Application with Health Canada for the MiniMed™ 780G and Guardian™ 4 sensor. Please keep in mind that Health Canada has a period for reviewing the file and issuing a licence if the information meet the requirements. This process can take some time and we will provide updates when available.

Did you know

The MiniMed™ 770G system is enabled for future software upgrades. 

Medtronic is currently the only manufacturer that has software updates for both pump and CGM*, and, in fact, our future goals include significant innovations with both products.

Girl looking at her insulin pump


Our goal for the future is aimed at developing technologies that are:

Simpler
Smarter
Smaller

PLANNED FUTURE PRODUCT INNOVATIONS AND GOALS

All referenced product innovations are in development. Such innovations are not licensed for sale in Canada and will require Health Canada review and licencing prior to being made available for sale.

Medtronic Diabetes Innovation Product pipeline

† Investigational. Not licensed for sale in Canada for any use and not commercially available in Canada.
†† In development. Potential future technology. Not licensed for sale in Canada and not commercially available. The innovations described above are all currently in development. Features and performances of future technologies may vary. Access to future technologies are contingent upon regulatory approval. Approval timelines are subject to the regulatory process of individual countries and regions and are  not guaranteed.

STAY INFORMED

Simply complete the form below:

By submitting this form you are consenting to and confirm the following:

  • That Medtronic can communicate with you regarding our diabetes products by telephone, fax, mail and/or e-mail.
  • That Medtronic stores information, including personal health information, on systems located outside of Canada.
  • That you have read and are aware of our privacy policy.
  • That you grant Medtronic of Canada permission to send you updates on diabetes and diabetes technology.
  • You may revoke this permission at any time by emailing medtronicdiabetescc@medtronic.com
  • Medtronic respects the confidentiality of personal information. We assure you we will not share your personal information, except as otherwise noted in our privacy policy.

*

En date du 17 juin 2021